Stockholders' Equity | NOTE 6 – STOCKHOLDERS’ EQUITY Share Repurchase Program In November 2015 , the Company’s board of directors authorized a share repurchase program for common stock up to $100 millio n, which was increased in November 2016 to $125 million. In the first quarter of 2017, the Company completed the repurchase of all shares authorized under the program. Summary of share repurchase activity under the repurchase program: Three Months Ended Nine Months Ended September 30, September 30, September 30, September 30, 2017 2016 2017 2016 Number of shares acquired on the open market - 1,121,111 859,830 6,399,385 Average price per share $ - $ 14.92 $ 20.54 $ 13.82 Total cost of acquired shares (in millions) $ - $ 17 $ 18 $ 88 In total, we have acquired 8,537,410 shares under this program at an average price per share of $14.64 for a total cost of $1 25 million. There were 94,514, 448 shares o f common stock outstanding as of September 30, 2017 . Equity Compensation Plans Our 2011 Omnibus Incentive Plan originally had 3 ,250,000 shares reserved for issuance under the plan. In April 2015, our shareholders approved an additional 4,250,000 shares for reservation for issuance under the plan. The plan permits the issuance of stock options, stock appreciation rights, restricted stock, restricted stock units, performance shares, performance units and other stock-based and cash-based awards. Since the adoption of the 2011 Omnibus Incentive Plan, the Company’s Board of Directors has periodically granted stock options , restricted stock awards, restricted stock units and performance share units to directors and employees. Options and stock appreciation rights may not be granted at prices less than the fair market value of our common stock on the date of the grant, nor for a term exceeding ten years. For employees, vesting generally occurs ratably over a three to five year period on the anniversaries of the date specified in the employees’ respective stock option, restricted stock award, restricted stock unit and performance share unit award agreement s , subject to accelerated vesting under certain circumstances set forth in the agreements. Vesting for directors generally occurs on the on e -y ear anniversary of the grant date . In 201 7 , 164,098 performance share unit awards, 54 4,918 restricted stock units, and 63, 272 shares of restricted stock have been granted to employees and members of our board of directors . To date , since the plan’s inception in 2011 , before consideration of forfeitures , 5,860,597 shares have been granted to management, members of our board of d irectors and key employees under this plan. A Black-Scholes option-pricing model is used to estimate the fair value of the stock options. A Monte Carlo simulation is completed to estimate the fair value of performance share unit awards with a stock price performance component. We expense the fair value of all equity grants , including performance share unit awards, on a straight-line basis over the vesting period. Accumulated Other Comprehensive Loss Accumulated other comprehensive loss in the accompanying consolidated balance sheets consists of the following (in millions): September 30, December 31, 2017 2016 Currency translation adjustments $ (208) $ (233) Pension related adjustments (1) (1) Accumulated other comprehensive loss $ (209) $ (234) Earnings per Share Earnings per share are calculated in the table below (in millions , except per share amounts). Three Months Ended Nine Months Ended September 30, September 30, September 30, September 30, 2017 2016 2017 2016 Net income (loss) $ 3 $ (40) $ 15 $ (65) Less: Dividends on Series A Preferred Stock 6 6 18 18 Net loss attributable to common stockholders $ (3) $ (46) $ (3) $ (83) Weighted average basic shares outstanding 94.5 95.9 94.6 98.1 Effect of dilutive securities - - - - Weighted average diluted shares outstanding 94.5 95.9 94.6 98.1 Net loss per share: Basic $ (0.03) $ (0.48) $ (0.03) $ (0.85) Diluted $ (0.03) $ (0.48) $ (0.03) $ (0.85) Equity awards and shares of Preferred Stock are disregarded in the calculation of diluted earnings per share if they are determined to be anti-dilutive. For the three and nine months ended September 30, 2017 and 2016 , all of the shares of the Preferred Stock wer e anti-dilutive. For the three and nine months ended September 30, 2017 , we had approximately 3.6 million and 2.1 mil lion anti-dilutive stock options , respectively . For the three and nine months ended September 30, 2016, we had approximately 3.7 million and 3.6 million anti-dilutive stock options , respectively . There were 1.2 million ant i-dilutive restricted stock, restricted units or performance stock unit awards for the three and nine months ended September 30, 2017. There were 1.0 million and 0.8 million ant i-dilutive restricted stock, restricted units or performance stock unit awards for the three and nine months ended September 30, 2016 respec tively . |